Wilterding Markinsider trades
In SEC Form 4 filings, Wilterding Mark is listed as Chief Financial Officer of RxSight, Inc. (RXST). In the last 90 days, Wilterding Mark sold $54K of RxSight, Inc. (RXST) on the open market and bought none.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| RXSTRxSight, Inc. | Chief Financial Officer | 5 | Sep 9 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-02
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| RXSTRxSight, Inc. | Sep 5 | Sep 9 | D · derivative | 258,770 | $10.09 | $2,610,989 | not reported | No | Form 4 |
| RXSTRxSight, Inc. | Sep 5 | Sep 9 | A · derivative | 258,770 | $6.38 | $1,649,659 | 258,770 | No | Form 4 |
| RXSTRxSight, Inc. | Sep 2 | Sep 2 | S | 7,765 | $6.96 | Sale −$54,044 | 25,049 | No | Form 4 |
| RXSTRxSight, Inc. | Aug 31 | Sep 2 | M | 20,441 | not reported | not reported | 32,814 | No | Form 4 |
| RXSTRxSight, Inc. | Aug 31 | Sep 2 | M · derivative | 20,441 | $0.00 | $0 | 122,646 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.